(Q42445183)

31 October 2017

0 references

A general requirement for FcγRIIB co-engagement of agonistic anti-TNFR antibodies (English)

1 reference

31 October 2017

1 reference

2

Jeffrey V Ravetch

1 reference

31 October 2017

Fubin Li

1

1 reference

31 October 2017

23 August 2012

1 reference

31 October 2017

1 reference

31 October 2017

11

1 reference

31 October 2017

18

1 reference

31 October 2017

3343-3344

1 reference

Apoptotic and antitumor activity of death receptor antibodies require inhibitory Fcγ receptor engagement

31 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466534

Inhibitory Fcγ receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466534

An Fcγ receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cells

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466534

Fcgamma receptors as regulators of immune responses

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466534

Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466534

Signalling pathways of the TNF superfamily: a double-edged sword

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466534

Interaction with FcγRIIB is critical for the agonistic activity of anti-CD40 monoclonal antibody.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466534

Anti-tumor effects of depleting and non-depleting anti-CD27 monoclonal antibodies in immune-competent mice.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466534

Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22918247

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Fc gamma Rs modulate cytotoxicity of anti-Fas antibodies: implications for agonistic antibody-based therapeutics

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22918247

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/CC.21842

1 reference

31 October 2017

1 reference

31 October 2017

1 reference

PMCID

3466534